バイオマテリアル市場 : 2029年までの世界予測

Report Overview

The global biomaterialss market is projected to reach USD 64.2 Bn by 2029 from USD 45.2 Bn in 2024, at a CAGR of 7.3% during the forecast period of 2024 to 2029.

世界のバイオマテリアル市場は、2024年から2029年の予測期間中に7.3%のCAGRで、2024年の452億米ドルから2029年までに642億米ドルに達すると予測されています。

Factors such as the Increasing awareness of sustainable and biodegradable materials are predicted to uplift the market in the coming years. Additionally, rising prevalence of chronic diseases and aging populations worldwide is driving the demand for medical implants which will provide lucrative market growth. However, biocompatibility issues associated with biomaterials are predicted to restrict the market.

“The metallic biomaterials segment held the dominant share in the biomaterials market.”
Based on type, the global biomaterials market is segmented into polymeric (polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, polyetheretherketone, other polymeric biomaterials), metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver,  magnesium, and other metallic biomaterials), natural (hyaluronic acid, collagen, fibrin, cellulose, chitin, alginate, gelatin, chitosan, silk, other natural biomaterials), and ceramic (calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon and glass). The conventional use of metallic biomaterials is expected to drive the expansion of the biomaterials market.

“The largest share of 2023 was occupied by the Orthopedic segment”
Based on application, the biomaterials market is classified into Tissue Engineering (Inorganic Nanoparticles, Nanomaterials, Scaffolds), Ophthalmology (Intraocular Lenses, Synthetic Corneas, Contact Lenses, Functional Replacement of Ocular Tissues, Other Ophthalmology Products), Neurological/Central Nervous System, (Neural Stem Cell Encapsulation Products, Cortical Neural Prosthetics, Hydrogel Scaffolds, Shunting Systems), Cardiovascular (Guidewires, Catheters, Implantable Cardiac Defibrillators, Stents, Sensors, Vascular Grafts, Heart Valves, Other Cardiovascular Products), Wound Healing (Internal Tissue Sealants, Surgical Hemostats, Hernia Meshes, Wound Closure Devices, [Staples, Sutures], Adhesion Barriers, Skin Substitutes), Urinary (Urethral Stents, Urinary Catheters, Other Urinary Products), Dental (Tissue Regeneration Materials, Dental Bone Grafts & Substitutes, Dental Membranes, Dental Implants), Plastic Surgery (Acellular Dermal Matrices, Facial Wrinkle Treatment Devices, Bioengineered Skins, Craniofacial Surgery Products, Soft Tissue Fillers, Peripheral Nerve Repair Devices), and Other Applications (Bariatric Surgery, Gastrointestinal, Drug Delivery Systems). This is due to the rise in the prevalence of musculoskeletal injuries, osteoporosis, and osteoarthritis and other orthopedic disorders.

“APAC region estimated to grow at a faster pace.”
The biomaterials market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. APAC region is projected to grow at the highest CAGR during the forecast period. are expected to support biomaterials market growth in the region. Increasing awareness of personalized medicine,  technological advancements and innovation and rising incidence of chronic diseases are the reasons which support market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80%, and Demand Side – 20%
• By Designation (Supply Side): Managers – 45%, CXOs & Directors – 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%
List of Companies Profiled in the Report:
• BASF SE (Germany)
• Covestro AG (Germany)
• Celanese Corporation (US)
• Carpenter Technology Corporation (US)
• DSM (Netherlands)
• Corbion NV (Netherlands)
• Evonik Industries AG (Germany)
• Victrex Plc (UK)
• CeramTec GmbH (Germany)
• Mitsubishi Chemical Group Corporation (Japan)
• CoorsTek Inc. (US)
• Berkeley Advanced Biomaterials (US)
• CAM Bioceramics B.V. (Netherlands)
• Zeus Company Inc. (US)
• AMETEK Inc.(US)
• GELITA AG (Germany)
• The RDI Group (Collagen Solutions (US) LLC)
• Biocomposites (England)
• Noble Biomaterials (US)
• Regenity (US)
• Kuraray Co. Ltd. (Japan)
• Solesis (US)
• Institut Straumann AG (Switzerland)
• Foster Corporation (US)
• CDI Products (US).

Research Coverage:
This report provides a detailed picture of the biomaterials market. It aims to estimate the size and future growth potential of the market across different segments, such as type, application and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall biomaterials market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (Growing demand for biomaterials in wound healing and plastic surgery, growing use of biomaterials in various therapeutic areas, rising funding and investments in regenerative and personized medicine and growing demand for implantable devices), restraints (Biocompatibility issues), opportunities (Growing interest in bioabsorbable biomaterials, expanding healthcare market in emerging economies, rising opportunities in personalized biomaterials, smart biomaterials, nanoengineered biomaterials, and sustainable biomaterials) and challenges (durability and long-term performance issues) are influencing the growth of biomaterials market.
• Product Development/Innovation: Detailed insights on newly launched products of the biomaterials market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the biomaterials market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biomaterials market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc.(US), GELITA AG (Germany) and among others in the biomaterials market. 

Table of Contents

1            INTRODUCTION            89

1.1         STUDY OBJECTIVES      89

1.2         MARKET DEFINITION   89

1.2.1      INCLUSIONS & EXCLUSIONS     89

1.3         MARKET SCOPE             90

1.3.1      MARKETS COVERED     90

1.3.2      YEARS CONSIDERED     91

1.3.3      CURRENCY CONSIDERED          91

1.4         RESEARCH LIMITATIONS           91

1.5         STAKEHOLDERS            92

1.6         SUMMARY OF CHANGES            92

1.7         RECESSION IMPACT      93

2            RESEARCH METHODOLOGY     94

2.1         RESEARCH DATA           94

FIGURE 1           RESEARCH DESIGN       94

2.1.1      SECONDARY DATA       95

2.1.2      PRIMARY DATA 96

FIGURE 2           BIOMATERIALS MARKET: BREAKDOWN OF PRIMARIES 96

2.2         MARKET SIZE ESTIMATION       97

FIGURE 3           BIOMATERIALS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023             97

FIGURE 4           MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023             98

FIGURE 5           ILLUSTRATIVE EXAMPLE OF BASF SE: REVENUE SHARE ANALYSIS, 2023 98

2.2.1      INSIGHTS FROM PRIMARIES      100

FIGURE 6           MARKET VALIDATION FROM PRIMARY EXPERTS           100

2.2.2      SEGMENT ASSESSMENT (BY TYPE AND APPLICATION) 100

FIGURE 7           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       100

2.3         GROWTH RATE ASSUMPTIONS 101

FIGURE 8           BIOMATERIALS MARKET: CAGR PROJECTIONS, 2024–2029              102

FIGURE 9           BIOMATERIALS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       102

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    103

FIGURE 10         DATA TRIANGULATION METHODOLOGY         103

2.5         STUDY ASSUMPTIONS  104

2.6         RISK ANALYSIS 104

2.7         IMPACT OF ECONOMIC RECESSION ON BIOMATERIALS MARKET              104

TABLE 1             GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)         105

TABLE 2             US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)  105

TABLE 3             US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)  105

3            EXECUTIVE SUMMARY 106

FIGURE 11         BIOMATERIALS MARKET, BY TYPE, 2024 VS 2029 (USD BILLION)              106

FIGURE 12         BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2024 VS. 2029 (USD MILLION)       107

FIGURE 13         BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2024 VS. 2029 (USD MILLION)       108

FIGURE 14         REGIONAL SNAPSHOT OF BIOMATERIALS MARKET      109

4            PREMIUM INSIGHTS      110

4.1         BIOMATERIALS MARKET OVERVIEW     110

FIGURE 15         INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE MARKET            110

4.2         NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE AND COUNTRY (2023)   111

FIGURE 16         US AND METALLIC BIOMATERIALS COMMANDED LARGEST SHARE IN NORTH AMERICAN BIOMATERIALS MARKET IN 2023 111

4.3         BIOMATERIALS MARKET, BY TYPE         112

FIGURE 17         METALLIC BIOMATERIALS TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD         112

4.4         BIOMATERIALS MARKET, BY APPLICATION       113

FIGURE 18         ORTHOPEDIC SEGMENT TO GROW AT HIGHEST CAGR DURING STUDY PERIOD            113

5            MARKET OVERVIEW     114

5.1         INTRODUCTION            114

5.2         MARKET DYNAMICS     114

FIGURE 19         BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    114

5.2.1      DRIVERS            115

5.2.1.1   Growing demand for biomaterials in wound healing and plastic surgery   115

5.2.1.2   Growing use of biomaterials in various therapeutic areas           115

5.2.1.3   Rising funding and investments in regenerative and personalized medicine              116

5.2.1.4   Growing demand for implantable devices      116

5.2.2      RESTRAINTS     117

5.2.2.1   Biocompatibility issues      117

5.2.3      OPPORTUNITIES           118

5.2.3.1   Growing interest in bioabsorbable biomaterials           118

5.2.3.2   Expanding healthcare market in emerging economies  118

5.2.3.3   Rising opportunities in personalized, smart, nanoengineered, and sustainable biomaterials         119

5.2.4      CHALLENGES   120

5.2.4.1   Durability and long-term performance issues 120

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 121

FIGURE 20         BIOMATERIALS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES         121

5.4         PRICING ANALYSIS        121

5.4.1      AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT              121

TABLE 4             AVERAGE SELLING PRICE OF BIOMATERIAL PRODUCTS              121

TABLE 5             AVERAGE SELLING TREND OF BIOMATERIAL PRODUCTS, BY REGION             122

5.5         VALUE CHAIN ANALYSIS            123

FIGURE 21         BIOMATERIALS MARKET: VALUE CHAIN ANALYSIS        123

5.6         SUPPLY CHAIN ANALYSIS          124

FIGURE 22         BIOMATERIALS MARKET: SUPPLY CHAIN ANALYSIS      124

TABLE 6             BIOMATERIALS MARKET: SUPPLY CHAIN ANALYSIS      125

5.7         ECOSYSTEM ANALYSIS 126

FIGURE 23         BIOMATERIALS MARKET: ECOSYSTEM/MARKET MAP   126

5.7.1      METALLIC BIOMATERIALS VENDORS   126

TABLE 7             METALLIC BIOMATERIALS VENDORS   126

5.7.2      CERAMIC BIOMATERIALS VENDORS     127

TABLE 8             CERAMIC BIOMATERIALS VENDORS     127

5.7.3      POLYMERIC BIOMATERIALS VENDORS 127

TABLE 9             POLYMERIC BIOMATERIALS VENDORS 127

5.7.4      NATURAL BIOMATERIALS VENDORS    128

TABLE 10           NATURAL BIOMATERIALS VENDORS    128

5.7.5      BIOMATERIALS END USERS       128

TABLE 11           BIOMATERIALS END USERS       129

5.7.6      BIOMATERIALS REGULATORY BODIES 129

TABLE 12           BIOMATERIALS REGULATORY BODIES 129

5.8         TECHNOLOGY ANALYSIS           130

5.9         PATENT ANALYSIS        131

5.9.1      METHODOLOGY           131

5.9.2      PATENTS FILED, BY DOCUMENT TYPE, 2014–2024          131

TABLE 13           PATENTS FILED, 2014–2024        131

5.9.3      INNOVATION AND PATENT APPLICATIONS      131

FIGURE 24         TOTAL NUMBER OF PATENTS GRANTED, 2014–2023      131

5.9.4      TOP APPLICANTS          132

FIGURE 25         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024         132

FIGURE 26         REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024              132

TABLE 14           TOP 12 PATENT OWNERS IN BIOMATERIALS MARKET, 2014–2024      133

TABLE 15           PATENTS IN BIOMATERIALS MARKET, 2023       133

5.10       TRADE DATA    135

5.10.1    STAINLESS STEEL          135

TABLE 16           IMPORT VALUE FOR STAINLESS STEEL, 2018–2022 (USD)              135

TABLE 17           EXPORT VALUE FOR STAINLESS STEEL, 2018–2022 (USD)              136

TABLE 18           IMPORT VOLUME FOR STAINLESS STEEL, 2018–2022 (TONS)              136

TABLE 19           EXPORT VOLUME FOR STAINLESS STEEL, 2018–2022 (TONS)              137

5.10.2    SILVER 137

TABLE 20           IMPORT VALUE FOR SILVER, 2018–2022 (USD)   137

TABLE 21           EXPORT VALUE FOR SILVER, 2018–2022 (USD)   138

TABLE 22           IMPORT VOLUME FOR SILVER, 2018–2022 (TONS)           138

TABLE 23           EXPORT VOLUME FOR SILVER, 2018–2022 (TONS)           139

5.10.3    ALUMINUM OXIDE        139

TABLE 24           IMPORT VALUE FOR ALUMINUM OXIDE, 2018–2022 (USD)              139

TABLE 25           EXPORT VALUE FOR ALUMINUM OXIDE, 2018–2022 (USD)              140

TABLE 26           IMPORT VOLUME FOR ALUMINUM OXIDE, 2018–2022 (TONS)              140

TABLE 27           EXPORT VOLUME FOR ALUMINUM OXIDE, 2018–2022 (TONS)              141

5.10.4    SILICONE          141

TABLE 28           IMPORT VALUE FOR SILICONE, 2018–2022 (USD)            141

TABLE 29           EXPORT VALUE FOR SILICONE, 2018–2022 (USD)            142

TABLE 30           IMPORT VOLUME FOR SILICONE, 2018–2022 (TONS)      142

TABLE 31           EXPORT VOLUME FOR SILICONE, 2018–2022 (TONS)      143

5.10.5    CELLULOSE      143

TABLE 32           IMPORT VALUE FOR CELLULOSE, 2018–2022 (USD)        143

TABLE 33           EXPORT VALUE FOR CELLULOSE, 2018–2022 (USD)        144

TABLE 34           IMPORT VOLUME FOR CELLULOSE, 2018–2022 (TONS)  144

TABLE 35           EXPORT VOLUME FOR CELLULOSE, 2018–2022 (TONS)  145

5.10.6    GELATIN           145

TABLE 36           IMPORT VALUE FOR GELATIN, 2018–2022 (USD)             145

TABLE 37           EXPORT VALUE FOR GELATIN, 2018–2022 (USD)             146

TABLE 38           IMPORT VOLUME FOR GELATIN, 2018–2022 (TONS)       146

TABLE 39           EXPORT VOLUME FOR GELATIN, 2018–2022 (TONS)       147

5.11       KEY CONFERENCES & EVENTS IN 2024–2025       147

TABLE 40           BIOMATERIALS CONFERENCES IN 2024–2025     147

5.12       REGULATORY LANDSCAPE       153

5.12.1    FDA REGULATIONS ON BIOMATERIALS             153

5.12.2    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          153

TABLE 41           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         153

TABLE 42           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 154

TABLE 43           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         155

TABLE 44           REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         156

5.13       PORTER’S FIVE FORCES ANALYSIS         157

TABLE 45           BIOMATERIALS MARKET: PORTER’S FIVE FORCES ANALYSIS              157

5.13.1    THREAT OF NEW ENTRANTS    157

5.13.2    THREAT OF SUBSTITUTES         158

5.13.3    BARGAINING POWER OF BUYERS           158

5.13.4    BARGAINING POWER OF SUPPLIERS     158

5.13.5    DEGREE OF COMPETITION       158

5.14       KEY STAKEHOLDERS & BUYING CRITERIA          159

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         159

TABLE 46           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS             159

5.14.2    BUYING CRITERIA FOR BIOMATERIAL PRODUCTS         159

FIGURE 27         KEY BUYING CRITERIA FOR END USERS              159

TABLE 47           KEY BUYING CRITERIA FOR TOP THREE END USERS      160

6            BIOMATERIALS MARKET, BY TYPE         161

6.1         INTRODUCTION            162

TABLE 48           IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION  162

TABLE 49           BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)              163

6.2         METALLIC BIOMATERIALS        163

TABLE 50           BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)             164

TABLE 51           BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)       164

6.2.1      STAINLESS STEEL          165

6.2.1.1   Stainless steel to command largest share in metallic biomaterials segment during forecast period     165

TABLE 52           STAINLESS STEEL MARKET, BY REGION, 2022–2029 (USD MILLION)          165

6.2.2      TITANIUM & TITANIUM ALLOYS            166

6.2.2.1   Growing number of joint replacement procedures to aid segment growth 166

TABLE 53           TITANIUM & TITANIUM ALLOYS MARKET, BY REGION, 2022–2029 (USD MILLION)     166

6.2.3      COBALT-CHROME ALLOYS       167

6.2.3.1   Low cost and high corrosion resistance to propel segment growth            167

TABLE 54           COBALT-CHROME ALLOYS MARKET, BY REGION, 2022–2029 (USD MILLION) 167

6.2.4      SILVER 167

6.2.4.1   Toxic properties and low aesthetic appeal to limit segment growth           167

TABLE 55           SILVER MARKET, BY REGION, 2022–2029 (USD MILLION)              168

6.2.5      GOLD   168

6.2.5.1   Increasing use in drug delivery, gene therapy, diagnosis, and tissue regeneration to drive segment  168

TABLE 56           GOLD MARKET, BY REGION, 2022–2029 (USD MILLION) 169

6.2.6      MAGNESIUM    169

6.2.6.1   High biocompatibility and low weight to support market growth 169

TABLE 57           MAGNESIUM MARKET, BY REGION, 2022–2029 (USD MILLION)              170

6.2.7      OTHER METALLIC BIOMATERIALS        170

TABLE 58           OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION)     171

6.3         POLYMERIC BIOMATERIALS     171

TABLE 59           APPLICATIONS OF SYNTHETIC POLYMERS        172

TABLE 60           BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)             172

TABLE 61           BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)       173

6.3.1      POLYMETHYLMETHACRYLATE 173

6.3.1.1   Better biocompatibility and improved safety to drive segment    173

TABLE 62           POLYMETHYLMETHACRYLATE MARKET, BY REGION, 2022–2029 (USD MILLION)     174

6.3.2      POLYETHYLENE            174

6.3.2.1   Better wear and tear resistance to boost segment growth           174

TABLE 63           POLYETHYLENE MARKET, BY REGION, 2022–2029 (USD MILLION)          175

6.3.3      POLYESTER      175

6.3.3.1   Better biodegradability and biocompatibility to propel segment growth    175

TABLE 64           POLYESTER MARKET, BY REGION, 2022–2029 (USD MILLION)              176

6.3.4      POLYVINYLCHLORIDE 176

6.3.4.1   Affordability, high tensile strength, and ease of processing to drive segment growth   176

TABLE 65           POLYVINYLCHLORIDE MARKET, BY REGION, 2022–2029 (USD MILLION)          176

6.3.5      SILICONE RUBBER         177

6.3.5.1   Non-reactivity, stability, and better resistance to extreme environments and temperatures to aid segment growth 177

TABLE 66           SILICONE RUBBER MARKET, BY REGION, 2022–2029 (USD MILLION)          177

6.3.6      NYLON 177

6.3.6.1   Increased use in biological applications and gastrointestinal surgeries to aid segment growth   177

TABLE 67           NYLON MARKET, BY REGION, 2022–2029 (USD MILLION)              178

6.3.7      POLYETHERETHERKETONE      178

6.3.7.1   High resistance to thermal degradation and aqueous environments to support segment growth   178

TABLE 68           POLYETHERETHERKETONE MARKET, BY REGION, 2022–2029 (USD MILLION) 178

6.3.8      OTHER POLYMERIC BIOMATERIALS     179

TABLE 69           OTHER POLYMERIC BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION)          179

6.4         CERAMIC BIOMATERIALS          179

TABLE 70           BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)             180

TABLE 71           BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)       180

6.4.1      CALCIUM PHOSPHATE 181

6.4.1.1   Better affinity to human body and higher bioresorbability to drive segment              181

TABLE 72           CALCIUM PHOSPHATE MARKET, BY REGION, 2022–2029 (USD MILLION)          181

6.4.2      ZIRCONIA          181

6.4.2.1   Bio-inertness and low wear rate to aid market growth  181

TABLE 73           ZIRCONIA MARKET, BY REGION, 2022–2029 (USD MILLION)              182

6.4.3      ALUMINUM OXIDE        182

6.4.3.1   Increasing use in hip replacements and dental implants to drive segment 182

TABLE 74           ALUMINUM OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION)          183

6.4.4      CALCIUM SULFATE       183

6.4.4.1   Increased popularity and adoption of tissue regeneration products to limit segment growth   183

TABLE 75           CALCIUM SULFATE MARKET, BY REGION, 2022–2029 (USD MILLION)          184

6.4.5      CARBON            184

6.4.5.1   Increasing use in regenerative medicine and cancer treatment to drive segment              184

TABLE 76           CARBON MARKET, BY REGION, 2022–2029 (USD MILLION)              185

6.4.6      GLASS  185

6.4.6.1   Rising number of orthopedic and dental procedures to boost segment growth              185

TABLE 77           GLASS MARKET, BY REGION, 2022–2029 (USD MILLION) 186

6.5         NATURAL BIOMATERIALS         186

TABLE 78           APPLICATIONS OF NATURAL BIOMATERIALS   186

TABLE 79           BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)             187

TABLE 80           BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)       188

6.5.1      HYALURONIC ACID       188

6.5.1.1   Rising prevalence of osteoarthritis among geriatric population to drive segment              188

TABLE 81           HYALURONIC ACID MARKET, BY REGION, 2022–2029 (USD MILLION)          189

6.5.2      COLLAGEN       189

6.5.2.1   Biocompatibility, biodegradability, accessibility, and efficient production processes to drive market   189

TABLE 82           COLLAGEN MARKET, BY REGION, 2022–2029 (USD MILLION)              190

6.5.3      FIBRIN  190

6.5.3.1   High utilization in wound healing and blood clotting to aid market growth              190

TABLE 83           FIBRIN MARKET, BY REGION, 2022–2029 (USD MILLION)              191

6.5.4      CELLULOSE      191

6.5.4.1   Better biodegradability, water-retention capability, and renewability to propel market growth     191

TABLE 84           CELLULOSE MARKET, BY REGION, 2022–2029 (USD MILLION)              192

6.5.5      CHITIN 192

6.5.5.1   Increased use in biomedical sector for wound dressings, drug delivery, and bone repair to drive market        192

TABLE 85           CHITIN MARKET, BY REGION, 2022–2029 (USD MILLION)              193

6.5.6      ALGINATES       193

6.5.6.1   Increased use in gastric reflux treatment to propel market growth            193

TABLE 86           ALGINATES MARKET, BY REGION, 2022–2029 (USD MILLION)              194

6.5.7      GELATIN           194

6.5.7.1   Cost-effectiveness and easy manufacturing process to drive segment growth              194

TABLE 87           GELATIN MARKET, BY REGION, 2022–2029 (USD MILLION)              195

6.5.8      CHITOSAN        195

6.5.8.1   Non-toxicity, antimicrobial attributes, and functional versatility to aid market growth   195

TABLE 88           CHITOSAN MARKET, BY REGION, 2022–2029 (USD MILLION)              196

6.5.9      SILK      196

6.5.9.1   Flexibility, glossiness, and adhesive abilities to boost market growth        196

TABLE 89           SILK MARKET, BY REGION, 2022–2029 (USD MILLION)    197

6.5.10    OTHER NATURAL BIOMATERIALS         197

TABLE 90           OTHER NATURAL BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION)     198

7            BIOMATERIALS MARKET, BY APPLICATION       199

7.1         INTRODUCTION            200

TABLE 91           BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          200

7.2         ORTHOPEDIC  200

TABLE 92           BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       201

TABLE 93           BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)  201

7.2.1      JOINT REPLACEMENT  202

TABLE 94           BIOMATERIALS MARKET FOR JOINT REPLACEMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      202

TABLE 95           BIOMATERIALS MARKET FOR JOINT REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 203

7.2.1.1   Knee replacement 203

7.2.1.1.1 Growing number of knee replacement procedures to drive market growth              203

TABLE 96           BIOMATERIALS MARKET FOR KNEE REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 204

7.2.1.2   Hip replacement  204

7.2.1.2.1 Large number of procedures performed to support market growth           204

TABLE 97           BIOMATERIALS MARKET FOR HIP REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 205

7.2.1.3   Shoulder replacement        205

7.2.1.3.1 Extensive use of biomaterials in shoulder replacement procedures to boost market              205

TABLE 98           BIOMATERIALS MARKET FOR SHOULDER REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 206

7.2.1.4   Other joint replacement procedures 206

TABLE 99           BIOMATERIALS MARKET FOR OTHER JOINT REPLACEMENT PROCEDURES, BY REGION, 2022–2029 (USD MILLION)   207

7.2.2      BIORESORBABLE TISSUE FIXATION       207

TABLE 100         BIOMATERIALS MARKET FOR BIORESORBABLE TISSUE FIXATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)      208

TABLE 101         BIOMATERIALS MARKET FOR BIORESORBABLE TISSUE FIXATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          208

7.2.2.1   Suture anchors     208

7.2.2.1.1 Growing awareness about suture anchor devices to drive market growth  208

TABLE 102         BIOMATERIALS MARKET FOR SUTURE ANCHORS, BY REGION, 2022–2029 (USD MILLION)          209

7.2.2.2   Interference screws            209

7.2.2.2.1 Increasing awareness about ACL to contribute to market growth             209

TABLE 103         BIOMATERIALS MARKET FOR INTERFERENCE SCREWS, BY REGION, 2022–2029 (USD MILLION)       210

7.2.2.3   Meniscal repair tacks         210

7.2.2.3.1 Rising sports injuries to drive growth             210

TABLE 104         BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2022–2029 (USD MILLION)       210

7.2.2.4   Meshes  211

7.2.2.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants to increase demand for meshes         211

TABLE 105         BIOMATERIALS MARKET FOR MESHES, BY REGION, 2022–2029 (USD MILLION) 211

7.2.3      SPINE SURGERY             211

TABLE 106         BIOMATERIALS MARKET FOR SPINE SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       212

TABLE 107         BIOMATERIALS MARKET FOR SPINE SURGERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)  212

7.2.3.1   Spinal fusion        212

7.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth     212

TABLE 108         BIOMATERIALS MARKET FOR SPINAL FUSION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)  213

7.2.3.2   Minimally invasive fusion   213

7.2.3.2.1 Faster recovery associated with minimally invasive fusion procedures to drive demand 213

TABLE 109         BIOMATERIALS MARKET FOR MINIMALLY INVASIVE FUSION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 214

7.2.3.3   Motion preservation & dynamic stabilization 214

TABLE 110         BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)          214

TABLE 111         BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          215

7.2.3.3.1 Pedicle-based rod systems 215

7.2.3.3.1.1           Rising geriatric population to favor market growth       215

TABLE 112         BIOMATERIALS MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2022–2029 (USD MILLION)  216

7.2.3.3.2 Interspinous spacers          216

7.2.3.3.2.1           High prevalence of degenerative spinal conditions to contribute to growth   216

TABLE 113         BIOMATERIALS MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2022–2029 (USD MILLION)       217

7.2.3.3.3 Artificial discs      217

7.2.3.3.3.1           High biocompatibility to increase use of artificial discs 217

TABLE 114         BIOMATERIALS MARKET FOR ARTIFICIAL DISCS, BY REGION, 2022–2029 (USD MILLION)          218

7.2.4      FRACTURE FIXATION   218

TABLE 115         BIOMATERIALS MARKET FOR FRACTURE FIXATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)           218

TABLE 116         BIOMATERIALS MARKET FOR FRACTURE FIXATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 219

7.2.4.1   Bone plates          219

7.2.4.1.1 Growing use of biomaterials in bone plates to aid growth           219

TABLE 117         BIOMATERIALS MARKET FOR BONE PLATES, BY REGION, 2022–2029 (USD MILLION)     219

7.2.4.2   Screws   220

7.2.4.2.1 Extensive use of screws in orthopedic procedures to boost market            220

TABLE 118         BIOMATERIALS MARKET FOR SCREWS, BY REGION, 2022–2029 (USD MILLION) 220

7.2.4.3   Pins       220

7.2.4.3.1 Growing use of metallic biomaterials in pins to propel growth    220

TABLE 119         BIOMATERIALS MARKET FOR PINS, BY REGION, 2022–2029 (USD MILLION) 221

7.2.4.4   Rods      221

7.2.4.4.1 Growing preference for rods for fracture treatment to fuel growth           221

TABLE 120         BIOMATERIALS MARKET FOR RODS, BY REGION, 2022–2029 (USD MILLION) 221

7.2.4.5   Wires     222

7.2.4.5.1 Extensive use of wires to treat fractures of small bones to aid growth        222

TABLE 121         BIOMATERIALS MARKET FOR WIRES, BY REGION, 2022–2029 (USD MILLION) 222

7.2.5      ORTHOBIOLOGICS       222

7.2.5.1   Rising cases of osteoarthritis to drive growth  222

TABLE 122         BIOMATERIALS MARKET FOR ORTHOBIOLOGICS APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 223

7.3         CARDIOVASCULAR       223

TABLE 123         BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)           224

TABLE 124         BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 224

7.3.1      CATHETERS      225

7.3.1.1   Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market    225

TABLE 125         BIOMATERIALS MARKET FOR CATHETERS, BY REGION, 2022–2029 (USD MILLION)     225

7.3.2      STENTS              225

7.3.2.1   Increasing number of coronary intervention procedures to boost demand for implantable stents              225

TABLE 126         BIOMATERIALS MARKET FOR STENTS, BY REGION, 2022–2029 (USD MILLION) 226

7.3.3      IMPLANTABLE CARDIAC DEFIBRILLATORS       226

7.3.3.1   Growing geriatric population to increase demand for implantable cardiac defibrillators        226

TABLE 127         BIOMATERIALS MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2022–2029 (USD MILLION)           227

7.3.4      PACEMAKERS   227

7.3.4.1   High prevalence of bradycardia to drive demand for pacemakers             227

TABLE 128         BIOMATERIALS MARKET FOR PACEMAKERS, BY REGION, 2022–2029 (USD MILLION)     228

7.3.5      SENSORS           228

7.3.5.1   Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors   228

TABLE 129         BIOMATERIALS MARKET FOR SENSORS, BY REGION, 2022–2029 (USD MILLION) 228

7.3.6      HEART VALVES 229

7.3.6.1   Growing geriatric population to increase demand for prosthetic valves    229

TABLE 130         BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS              229

TABLE 131         BIOMATERIALS MARKET FOR HEART VALVES, BY REGION, 2022–2029 (USD MILLION)          230

7.3.7      VASCULAR GRAFTS       230

7.3.7.1   Growing number of research studies to open opportunities for growth     230

TABLE 132         BIOMATERIALS MARKET FOR VASCULAR GRAFTS, BY REGION, 2022–2029 (USD MILLION)          231

7.3.8      GUIDEWIRES    231

7.3.8.1   Extensive use of guidewires for guiding catheters and placing stents to boost market   231

TABLE 133         BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION, 2022–2029 (USD MILLION)     232

7.3.9      OTHER CARDIOVASCULAR PRODUCTS 232

TABLE 134         BIOMATERIALS MARKET FOR OTHER CARDIOVASCULAR PRODUCTS, BY REGION, 2022–2029 (USD MILLION)        233

7.4         OPHTHALMOLOGY      233

TABLE 135         BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)           233

TABLE 136         BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 234

7.4.1      CONTACT LENSES         234

7.4.1.1   High cases of refractive errors and preference for contact lenses over spectacles to drive market        234

TABLE 137         BIOMATERIALS MARKET FOR CONTACT LENSES, BY REGION, 2022–2029 (USD MILLION)          235

7.4.2      INTRAOCULAR LENSES 235

7.4.2.1   Increasing prevalence of cataracts to drive number of cataract surgeries performed              235

TABLE 138         BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION, 2022–2029 (USD MILLION)       236

7.4.3      FUNCTIONAL REPLACEMENT OF OCULAR TISSUE         236

7.4.3.1   Increasing funding and research activities for development of bionic eyes to drive market   236

TABLE 139         BIOMATERIALS MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUE, BY REGION, 2022–2029 (USD MILLION)       237

7.4.4      SYNTHETIC CORNEAS  237

7.4.4.1   Growing number of corneal blindness cases worldwide to boost demand for synthetic collagen biomaterials        237

TABLE 140         BIOMATERIALS MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2022–2029 (USD MILLION)       238

7.4.5      OTHER OPHTHALMOLOGY PRODUCTS             238

TABLE 141         BIOMATERIALS MARKET FOR OTHER OPHTHALMOLOGY PRODUCTS, BY REGION, 2022–2029 (USD MILLION)        238

7.5         DENTAL            239

TABLE 142         BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)   239

TABLE 143         BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       239

7.5.1      DENTAL IMPLANTS      240

7.5.1.1   Increasing awareness of dental services and improving quality of dental products to boost growth    240

TABLE 144         PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN US (2016)      240

TABLE 145         BIOMATERIALS MARKET FOR DENTAL IMPLANTS, BY REGION, 2022–2029 (USD MILLION)          241

7.5.2      DENTAL BONE GRAFTS & SUBSTITUTES            241

7.5.2.1   Growing demand for dental implants among people opting for cosmetic dentistry to drive market growth       241

TABLE 146         BIOMATERIALS MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2022–2029 (USD MILLION)   242

7.5.3      DENTAL MEMBRANES  242

7.5.3.1   Growing use of dental membranes in oral and periodontal surgery to favor market growth   242

TABLE 147         BIOMATERIALS MARKET FOR DENTAL MEMBRANES, BY REGION, 2022–2029 (USD MILLION)       243

7.5.4      TISSUE REGENERATION MATERIALS     243

7.5.4.1   Increasing prevalence of periodontal disease to support growth  243

TABLE 148         BIOMATERIALS MARKET FOR TISSUE REGENERATION MATERIALS, BY REGION, 2022–2029 (USD MILLION)       244

7.6         PLASTIC SURGERY        244

TABLE 149         BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)           244

TABLE 150         BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 245

7.6.1      SOFT TISSUE FILLERS   245

7.6.1.1   Advantages such as long-lasting capacity and less allergic reactions to drive demand for soft tissue fillers            245

TABLE 151         BIOMATERIALS MARKET FOR SOFT TISSUE FILLERS, BY REGION, 2022–2029 (USD MILLION)       246

7.6.2      CRANIOFACIAL SURGERY PRODUCTS   246

7.6.2.1   Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries     246

TABLE 152         BIOMATERIALS MARKET FOR CRANIOFACIAL SURGERY PRODUCTS, BY REGION, 2022–2029 (USD MILLION)        247

7.6.3      FACIAL WRINKLE TREATMENT DEVICES            247

7.6.3.1   Increase in demand for non-surgical treatments to drive market growth   247

TABLE 153         BIOMATERIALS MARKET FOR FACIAL WRINKLE TREATMENT DEVICES, BY REGION, 2022–2029 (USD MILLION)            248

7.6.4      BIOENGINEERED SKINS              248

7.6.4.1   Growing applications of bioengineered skins to boost market     248

TABLE 154         BIOMATERIALS MARKET FOR BIOENGINEERED SKINS, BY REGION, 2022–2029 (USD MILLION)       248

7.6.5      PERIPHERAL NERVE REPAIR DEVICES   249

7.6.5.1   Increasing incidence of trauma cases to support growth             249

TABLE 155         BIOMATERIALS MARKET FOR PERIPHERAL NERVE REPAIR DEVICES, BY REGION, 2022–2029 (USD MILLION)            249

7.6.6      ACELLULAR DERMAL MATRICES           249

7.6.6.1   Ability of ADMs to provide mechanical support to boost demand            249

TABLE 156        BIOMATERIALS MARKET FOR ACELLULAR DERMAL MATRICES, BY REGION, 2022–2029 (USD MILLION)  250

7.7         WOUND HEALING         251

TABLE 157         BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)           251

TABLE 158         BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 251

7.7.1      WOUND CLOSURE DEVICES      252

TABLE 159         BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY TYPE, 2022–2029 (USD MILLION)             252

TABLE 160         BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2022–2029 (USD MILLION)       252

7.7.1.1   Sutures  253

7.7.1.1.1 Ability to use sutures as advanced biologically active components to drive demand              253

TABLE 161         BIOMATERIALS MARKET FOR WOUND CLOSURE SUTURES, BY REGION, 2022–2029 (USD MILLION)       253

7.7.1.2   Staples   254

7.7.1.2.1 Ability of staples to shorten closure by 70–80% compared to sutures to drive adoption 254

TABLE 162         BIOMATERIALS MARKET FOR WOUND CLOSURE STAPLES, BY REGION, 2022–2029 (USD MILLION)       254

7.7.2      SURGICAL HEMOSTATS             254

7.7.2.1   Ability of surgical hemostats to control bleeding and reduce need for frequent blood transfusions to boost market   254

TABLE 163         BIOMATERIALS MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2022–2029 (USD MILLION)       255

7.7.3      INTERNAL TISSUE SEALANTS   255

7.7.3.1   Ability of internal tissue sealants to control bleeding and hemorrhages to fuel growth   255

TABLE 164         BIOMATERIALS MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2022–2029 (USD MILLION)  255

7.7.4      ADHESION BARRIERS    256

7.7.4.1   Ability of adhesion barriers to promote inflammatory healing process to propel growth   256

TABLE 165         BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION, 2022–2029 (USD MILLION)       256

7.7.5      HERNIA MESHES            256

7.7.5.1   Growing use of meshes in hernia repair to boost market             256

TABLE 166         BIOMATERIALS MARKET FOR HERNIA MESHES, BY REGION, 2022–2029 (USD MILLION)          257

7.7.6      SKIN SUBSTITUTES       257

7.7.6.1   Diverse range of combinations of skin substitutes to boost demand          257

TABLE 167         BIOMATERIALS MARKET FOR SKIN SUBSTITUTES, BY REGION, 2022–2029 (USD MILLION)          258

7.8         TISSUE ENGINEERING  258

TABLE 168         BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)           259

TABLE 169         BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 259

7.8.1      SCAFFOLDS      259

7.8.1.1   Rise in organ transplantation procedures to drive market           259

TABLE 170         BIOMATERIALS MARKET FOR SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)     260

7.8.2      NANOMATERIALS         260

7.8.2.1   Rising research on nanotechnology to drive growth      260

TABLE 171         BIOMATERIALS MARKET FOR NANOMATERIALS, BY REGION, 2022–2029 (USD MILLION)          261

7.8.3      INORGANIC NANOPARTICLES  261

7.8.3.1   Growing demand for nanotechnological medical products to propel market              261

TABLE 172         BIOMATERIALS MARKET FOR INORGANIC NANOPARTICLES, BY REGION, 2022–2029 (USD MILLION)  261

7.9         NEUROLOGICAL/CENTRAL NERVOUS SYSTEM 262

TABLE 173         BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)              262

TABLE 174         BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)              262

7.9.1      SHUNTING SYSTEMS    263

7.9.1.1   Rising cases of hydrocephalus to boost market growth  263

TABLE 175         BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)       263

7.9.2      CORTICAL NEURAL PROSTHETICS        264

7.9.2.1   Growing use of CNPs to treat paralyzed patients to drive growth             264

TABLE 176         BIOMATERIALS MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2022–2029 (USD MILLION)  264

7.9.3      HYDROGEL SCAFFOLDS            264

7.9.3.1   Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds 264

TABLE 177         BIOMATERIALS MARKET FOR HYDROGEL SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)       265

7.9.4      NEURAL STEM CELL ENCAPSULATION PRODUCTS       265

7.9.4.1   Lack of substitutes for treatment of neurotrauma to boost market growth 265

TABLE 178         BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION PRODUCTS, BY REGION, 2022–2029 (USD MILLION)   266

7.10       URINARY           266

TABLE 179         BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)   267

TABLE 180         BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       267

7.10.1    URINARY CATHETERS  267

7.10.1.1 Development of novel coatings for urinary catheters to boost market       267

TABLE 181         BIOMATERIALS MARKET FOR URINARY CATHETERS, BY REGION, 2022–2029 (USD MILLION)       268

7.10.2    URETHRAL STENTS      268

7.10.2.1 Complications associated with urethral stents to limit market growth       268

TABLE 182         BIOMATERIALS MARKET FOR URETHRAL STENTS, BY REGION, 2022–2029 (USD MILLION)          269

7.10.3    OTHER URINARY PRODUCTS    269

TABLE 183         BIOMATERIALS MARKET FOR OTHER URINARY PRODUCTS, BY REGION, 2022–2029 (USD MILLION)       269

7.11       OTHER APPLICATIONS 270

TABLE 184        BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          270

TABLE 185         BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       270

7.11.1    DRUG DELIVERY SYSTEMS        271

7.11.1.1 Dependence of drug delivery systems on biomaterials due to biocompatibility to boost growth        271

TABLE 186         BIOMATERIALS MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2022–2029 (USD MILLION)       271

7.11.2    GASTROINTESTINAL    272

7.11.2.1 Wide usage of biomaterials in treatment of gastrointestinal diseases to drive market   272

TABLE 187         BIOMATERIALS MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 272

7.11.3    BARIATRIC SURGERY    273

7.11.3.1 Limited number of biomaterials used for bariatric surgery to hamper growth              273

TABLE 188         BIOMATERIALS MARKET FOR BARIATRIC SURGERY, BY REGION, 2022–2029 (USD MILLION)       273

8            BIOMATERIALS MARKET, BY REGION    274

8.1         INTRODUCTION            275

TABLE 189         BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION)          275

8.2         NORTH AMERICA          276

FIGURE 28         NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT              276

TABLE 190         NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          277

TABLE 191         NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)     277

TABLE 192         NORTH AMERICA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     278

TABLE 193         NORTH AMERICA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     278

TABLE 194         NORTH AMERICA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     279

TABLE 195         NORTH AMERICA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     279

TABLE 196         NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          280

TABLE 197         NORTH AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              281

TABLE 198         NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      281

TABLE 199         NORTH AMERICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          282

TABLE 200         NORTH AMERICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)     282

TABLE 201         NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  283

TABLE 202         NORTH AMERICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    283

TABLE 203         NORTH AMERICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          284

TABLE 204         NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              284

TABLE 205         NORTH AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      285

TABLE 206         NORTH AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  285

TABLE 207         NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  286

TABLE 208         NORTH AMERICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             286

TABLE 209         NORTH AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       287

TABLE 210         NORTH AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     287

TABLE 211         NORTH AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      288

TABLE 212         NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      288

8.2.1      NORTH AMERICA: RECESSION IMPACT 288

8.2.2      US         289

8.2.2.1   Rising incidence of cancer and ongoing research in developing biocompatible materials to drive market   289

TABLE 213         US: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          290

TABLE 214         US: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       290

TABLE 215         US: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)             291

TABLE 216         US: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       291

TABLE 217         US: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       292

TABLE 218         US: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 292

TABLE 219         US: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      293

TABLE 220         US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      293

TABLE 221         US: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          294

TABLE 222         US: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          294

TABLE 223         US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    295

TABLE 224         US: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          295

TABLE 225         US: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          295

TABLE 226         US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      296

TABLE 227         US: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             296

TABLE 228         US: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      297

TABLE 229         US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      297

TABLE 230         US: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 298

TABLE 231         US: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      298

TABLE 232         US: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 298

TABLE 233         US: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             299

TABLE 234         US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             299

8.2.3      CANADA            299

8.2.3.1   Growing incidence of cardiovascular diseases to propel market growth     299

TABLE 235         CANADA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          300

TABLE 236         CANADA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     300

TABLE 237         CANADA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     301

TABLE 238         CANADA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     301

TABLE 239         CANADA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     302

TABLE 240         CANADA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     302

TABLE 241         CANADA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      303

TABLE 242         CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      303

TABLE 243         CANADA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 304

TABLE 244         CANADA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          304

TABLE 245         CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  304

TABLE 246         CANADA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             305

TABLE 247         CANADA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 305

TABLE 248         CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      306

TABLE 249         CANADA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      306

TABLE 250         CANADA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      307

TABLE 251         CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      307

TABLE 252         CANADA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     308

TABLE 253         CANADA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      308

TABLE 254         CANADA: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          308

TABLE 255         CANADA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      309

TABLE 256         CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      309

8.3         EUROPE             310

TABLE 257         EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 310

TABLE 258         EUROPE: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          310

TABLE 259         EUROPE: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     311

TABLE 260         EUROPE: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     311

TABLE 261         EUROPE: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     312

TABLE 262         EUROPE: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     312

TABLE 263         EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     313

TABLE 264         EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      313

TABLE 265         EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      314

TABLE 266         EUROPE: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 314

TABLE 267         EUROPE: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          315

TABLE 268         EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  315

TABLE 269         EUROPE: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             316

TABLE 270         EUROPE: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 316

TABLE 271         EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      317

TABLE 272         EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      317

TABLE 273         EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      318

TABLE 274         EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      318

TABLE 275         EUROPE: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     319

TABLE 276         EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      319

TABLE 277         EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          319

TABLE 278         EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      320

TABLE 279        EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       320

8.3.1      EUROPE: RECESSION IMPACT   320

8.3.2      GERMANY         321

8.3.2.1   Rising focus on clinical research and patent approvals to aid market growth              321

TABLE 280         GERMANY: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          322

TABLE 281         GERMANY: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     322

TABLE 282         GERMANY: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     323

TABLE 283         GERMANY: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     323

TABLE 284         GERMANY: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     324

TABLE 285         GERMANY: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     324

TABLE 286         GERMANY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      325

TABLE 287         GERMANY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      325

TABLE 288         GERMANY: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 326

TABLE 289         GERMANY: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 326

TABLE 290         GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  326

TABLE 291         GERMANY: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             327

TABLE 292         GERMANY: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 327

TABLE 293         GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      328

TABLE 294         GERMANY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      328

TABLE 295         GERMANY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      329

TABLE 296         GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      329

TABLE 297         GERMANY: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          330

TABLE 298         GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       330

TABLE 299         GERMANY: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          330

TABLE 300         GERMANY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      331

TABLE 301         GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      331

8.3.3      UK         331

8.3.3.1   Increasing availability of funds and rising number of cardiovascular procedures to support market growth       331

TABLE 302         UK: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          332

TABLE 303         UK: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       332

TABLE 304         UK: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       333

TABLE 305         UK: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       333

TABLE 306         UK: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       334

TABLE 307         UK: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 334

TABLE 308         UK: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      335

TABLE 309         UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      335

TABLE 310         UK: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          336

TABLE 311         UK: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)     336

TABLE 312         UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    336

TABLE 313         UK: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          337

TABLE 314         UK: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          337

TABLE 315         UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      338

TABLE 316         UK: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             338

TABLE 317         UK: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      339

TABLE 318         UK: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      339

TABLE 319         UK: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 340

TABLE 320         UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      340

TABLE 321         UK: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 340

TABLE 322         UK: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             341

TABLE 323         UK: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             341

8.3.4      FRANCE             341

8.3.4.1   Increased healthcare expenditure and structured regulatory framework to drive market   341

TABLE 324         FRANCE: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          342

TABLE 325         FRANCE: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     342

TABLE 326         FRANCE: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     343

TABLE 327         FRANCE: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     343

TABLE 328         FRANCE: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     344

TABLE 329         FRANCE: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     344

TABLE 330         FRANCE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      345

TABLE 331         FRANCE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      345

TABLE 332         FRANCE: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 346

TABLE 333         FRANCE: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)          346

TABLE 334         FRANCE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  346

TABLE 335         FRANCE: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             347

TABLE 336         FRANCE: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 347

TABLE 337         FRANCE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      348

TABLE 338         FRANCE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      348

TABLE 339         FRANCE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      349

TABLE 340         FRANCE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      349

TABLE 341         FRANCE: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     350

TABLE 342         FRANCE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      350

TABLE 343         FRANCE: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          350

TABLE 344         FRANCE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      351

TABLE 345        FRANCE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       351

8.3.5      ITALY   351

8.3.5.1   Rising prevalence of neurological and cardiovascular disorders to boost market growth   351

TABLE 346         ITALY: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          352

TABLE 347         ITALY: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     353

TABLE 348        ITALY: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       353

TABLE 349         ITALY: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     354

TABLE 350         ITALY: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     354

TABLE 351         ITALY: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 355

TABLE 352         ITALY: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      355

TABLE 353         ITALY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      356

TABLE 354         ITALY: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 356

TABLE 355         ITALY: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)          357

TABLE 356         ITALY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    357

TABLE 357         ITALY: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          357

TABLE 358         ITALY: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 358

TABLE 359         ITALY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      358

TABLE 360         ITALY: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       359

TABLE 361         ITALY: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      359

TABLE 362         ITALY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      360

TABLE 363         ITALY: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     360

TABLE 364         ITALY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      360

TABLE 365         ITALY: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          361

TABLE 366         ITALY: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       361

TABLE 367         ITALY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       362

8.3.6      SPAIN   362

8.3.6.1   Increased focus on research for biomaterial development to propel market growth              362

TABLE 368         SPAIN: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          362

TABLE 369         SPAIN: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     363

TABLE 370        SPAIN: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       363

TABLE 371         SPAIN: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     364

TABLE 372         SPAIN: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     364

TABLE 373         SPAIN: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 365

TABLE 374         SPAIN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      365

TABLE 375         SPAIN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      366

TABLE 376         SPAIN: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 366

TABLE 377         SPAIN: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)          367

TABLE 378         SPAIN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    367

TABLE 379         SPAIN: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          367

TABLE 380         SPAIN: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 368

TABLE 381         SPAIN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      368

TABLE 382         SPAIN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       369

TABLE 383         SPAIN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      369

TABLE 384         SPAIN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      370

TABLE 385         SPAIN: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     370

TABLE 386         SPAIN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      371

TABLE 387         SPAIN: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          371

TABLE 388         SPAIN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       372

TABLE 389         SPAIN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       372

8.3.7      REST OF EUROPE           372

TABLE 390         REST OF EUROPE: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)     373

TABLE 391         REST OF EUROPE: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     373

TABLE 392         REST OF EUROPE: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     374

TABLE 393         REST OF EUROPE: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     374

TABLE 394         REST OF EUROPE: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     375

TABLE 395         REST OF EUROPE: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          375

TABLE 396         REST OF EUROPE: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              376

TABLE 397         REST OF EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      376

TABLE 398         REST OF EUROPE: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          377

TABLE 399         REST OF EUROPE: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)       377

TABLE 400         REST OF EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  378

TABLE 401         REST OF EUROPE: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    378

TABLE 402         REST OF EUROPE: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          379

TABLE 403         REST OF EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              379

TABLE 404         REST OF EUROPE: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      380

TABLE 405         REST OF EUROPE: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  380

TABLE 406         REST OF EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  381

TABLE 407         REST OF EUROPE: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             381

TABLE 408         REST OF EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       382

TABLE 409         REST OF EUROPE: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     382

TABLE 410         REST OF EUROPE: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      383

TABLE 411         REST OF EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      383

8.4         ASIA PACIFIC    384

FIGURE 29         ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT       384

TABLE 412         ASIA PACIFIC: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     385

TABLE 413         ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 385

TABLE 414         ASIA PACIFIC: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     386

TABLE 415         ASIA PACIFIC: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     386

TABLE 416         ASIA PACIFIC: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     387

TABLE 417         ASIA PACIFIC: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     387

TABLE 418         ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          388

TABLE 419         ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              389

TABLE 420         ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      389

TABLE 421         ASIA PACIFIC: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     390

TABLE 422         ASIA PACIFIC: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 390

TABLE 423         ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  391

TABLE 424         ASIA PACIFIC: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             391

TABLE 425         ASIA PACIFIC: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)     392

TABLE 426         ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              392

TABLE 427         ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      393

TABLE 428         ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  393

TABLE 429         ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      394

TABLE 430         ASIA PACIFIC: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          394

TABLE 431         ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       394

TABLE 432         ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     395

TABLE 433         ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      395

TABLE 434         ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      396

8.4.1      ASIA PACIFIC: RECESSION IMPACT        396

8.4.2      CHINA  397

8.4.2.1   Lucrative medical devices industry and large geriatric population to drive market              397

TABLE 435         CHINA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          398

TABLE 436         CHINA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     398

TABLE 437         CHINA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     399

TABLE 438         CHINA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     399

TABLE 439         CHINA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     400

TABLE 440         CHINA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 401

TABLE 441         CHINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      402

TABLE 442         CHINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      402

TABLE 443         CHINA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 403

TABLE 444         CHINA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          403

TABLE 445         CHINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    404

TABLE 446         CHINA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          404

TABLE 447         CHINA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 404

TABLE 448         CHINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      405

TABLE 449         CHINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       405

TABLE 450         CHINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      406

TABLE 451         CHINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      406

TABLE 452         CHINA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     407

TABLE 453         CHINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      407

TABLE 454         CHINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     407

TABLE 455         CHINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      408

TABLE 456         CHINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       408

8.4.3      JAPAN  408

8.4.3.1   Growing medical devices industry and rising aging population to support market growth   408

TABLE 457         JAPAN: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          409

TABLE 458         JAPAN: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     409

TABLE 459         JAPAN: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     410

TABLE 460         JAPAN: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     410

TABLE 461         JAPAN: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     411

TABLE 462         JAPAN: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 412

TABLE 463         JAPAN: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      413

TABLE 464         JAPAN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      413

TABLE 465         JAPAN: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 414

TABLE 466         JAPAN: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          414

TABLE 467         JAPAN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    414

TABLE 468         JAPAN: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          415

TABLE 469         JAPAN: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 415

TABLE 470         JAPAN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      416

TABLE 471         JAPAN: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       416

TABLE 472         JAPAN: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      417

TABLE 473         JAPAN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      417

TABLE 474         JAPAN: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     418

TABLE 475         JAPAN: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      418

TABLE 476         JAPAN: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     418

TABLE 477         JAPAN: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      419

TABLE 478         JAPAN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       419

8.4.4      INDIA   419

8.4.4.1   Large population base and growing focus on medical tourism to aid market growth              419

TABLE 479         INDIA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          420

TABLE 480         INDIA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     420

TABLE 481        INDIA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)       421

TABLE 482         INDIA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     421

TABLE 483         INDIA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     422

TABLE 484         INDIA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 422

TABLE 485         INDIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      423

TABLE 486         INDIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      423

TABLE 487         INDIA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 424

TABLE 488         INDIA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          424

TABLE 489         INDIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    424

TABLE 490         INDIA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          425

TABLE 491         INDIA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 425

TABLE 492         INDIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      426

TABLE 493         INDIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       426

TABLE 494         INDIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      427

TABLE 495         INDIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      427

TABLE 496         INDIA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     428

TABLE 497         INDIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      428

TABLE 498         INDIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     428

TABLE 499         INDIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      429

TABLE 500         INDIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       429

8.4.5      SOUTH KOREA 429

8.4.5.1   High demand for healthcare services and treatments to support market growth              429

TABLE 501         SOUTH KOREA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 430

TABLE 502         SOUTH KOREA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     430

TABLE 503         SOUTH KOREA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     431

TABLE 504         SOUTH KOREA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     431

TABLE 505         SOUTH KOREA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     432

TABLE 506         SOUTH KOREA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          432

TABLE 507         SOUTH KOREA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              433

TABLE 508         SOUTH KOREA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      433

TABLE 509         SOUTH KOREA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          434

TABLE 510         SOUTH KOREA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)     434

TABLE 511         SOUTH KOREA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  435

TABLE 512         SOUTH KOREA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       435

TABLE 513         SOUTH KOREA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)     436

TABLE 514         SOUTH KOREA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              436

TABLE 515         SOUTH KOREA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      437

TABLE 516         SOUTH KOREA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  437

TABLE 517         SOUTH KOREA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  438

TABLE 518        SOUTH KOREA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          438

TABLE 519         SOUTH KOREA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       439

TABLE 520         SOUTH KOREA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       439

TABLE 521         SOUTH KOREA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      440

TABLE 522         SOUTH KOREA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      440

8.4.6      AUSTRALIA       440

8.4.6.1   Increasing incidence of sports injuries and growing government investment in research to aid market growth          440

TABLE 523         AUSTRALIA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 441

TABLE 524         AUSTRALIA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     442

TABLE 525         AUSTRALIA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     442

TABLE 526         AUSTRALIA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     443

TABLE 527         AUSTRALIA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     443

TABLE 528         AUSTRALIA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     444

TABLE 529         AUSTRALIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      444

TABLE 530         AUSTRALIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      445

TABLE 531         AUSTRALIA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     445

TABLE 532         AUSTRALIA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 446

TABLE 533         AUSTRALIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  446

TABLE 534         AUSTRALIA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             446

TABLE 535         AUSTRALIA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)     447

TABLE 536         AUSTRALIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      447

TABLE 537         AUSTRALIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      448

TABLE 538         AUSTRALIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      448

TABLE 539         AUSTRALIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      449

TABLE 540         AUSTRALIA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          449

TABLE 541         AUSTRALIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       449

TABLE 542         AUSTRALIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     450

TABLE 543         AUSTRALIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      450

TABLE 544         AUSTRALIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      450

8.4.7      REST OF ASIA PACIFIC  451

TABLE 545         REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          451

TABLE 546         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 452

TABLE 547         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     452

TABLE 548         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)           453

TABLE 549         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 453

TABLE 550         REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           454

TABLE 551         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              455

TABLE 552         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        455

TABLE 553         REST OF ASIA PACIFIC: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             456

TABLE 554         REST OF ASIA PACIFIC: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          456

TABLE 555         REST OF ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  456

TABLE 556         REST OF ASIA PACIFIC: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    457

TABLE 557         REST OF ASIA PACIFIC: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             457

TABLE 558         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              458

TABLE 559         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      458

TABLE 560         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  459

TABLE 561         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  459

TABLE 562         REST OF ASIA PACIFIC: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       460

TABLE 563         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       460

TABLE 564         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       460

TABLE 565         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      461

TABLE 566         REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      461

8.5         LATIN AMERICA             462

TABLE 567         LATIN AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          462

TABLE 568         LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 462

TABLE 569         LATIN AMERICA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     463

TABLE 570         LATIN AMERICA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     463

TABLE 571         LATIN AMERICA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     464

TABLE 572         LATIN AMERICA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     464

TABLE 573         LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          465

TABLE 574         LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              465

TABLE 575         LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      466

TABLE 576         LATIN AMERICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          466

TABLE 577         LATIN AMERICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)     467

TABLE 578         LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  467

TABLE 579         LATIN AMERICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       467

TABLE 580         LATIN AMERICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          468

TABLE 581         LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              468

TABLE 582         LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      469

TABLE 583         LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  469

TABLE 584         LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  470

TABLE 585         LATIN AMERICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             470

TABLE 586         LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       470

TABLE 587         LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       471

TABLE 588         LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      471

TABLE 589         LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      471

8.5.1      LATIN AMERICA: RECESSION IMPACT   472

8.5.2      BRAZIL 472

8.5.2.1   Gradual increase in pharmaceutical R&D to support market growth         472

TABLE 590         BRAZIL: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          473

TABLE 591         BRAZIL: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     473

TABLE 592         BRAZIL: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     474

TABLE 593         BRAZIL: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     474

TABLE 594         BRAZIL: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     475

TABLE 595         BRAZIL: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 475

TABLE 596         BRAZIL: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      476

TABLE 597         BRAZIL: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      476

TABLE 598         BRAZIL: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 477

TABLE 599         BRAZIL: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          477

TABLE 600         BRAZIL: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    477

TABLE 601        BRAZIL: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          478

TABLE 602         BRAZIL: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 478

TABLE 603         BRAZIL: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      479

TABLE 604        BRAZIL: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       479

TABLE 605         BRAZIL: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      480

TABLE 606         BRAZIL: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      480

TABLE 607         BRAZIL: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     481

TABLE 608         BRAZIL: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      481

TABLE 609         BRAZIL: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     481

TABLE 610         BRAZIL: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      482

TABLE 611         BRAZIL: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       482

8.5.3      MEXICO             482

8.5.3.1   Increasing incidence of diabetes and growing geriatric population to aid market growth   482

TABLE 612         MEXICO: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          483

TABLE 613         MEXICO: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     483

TABLE 614         MEXICO: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     484

TABLE 615         MEXICO: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     484

TABLE 616         MEXICO: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     485

TABLE 617         MEXICO: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     485

TABLE 618         MEXICO: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      486

TABLE 619         MEXICO: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      486

TABLE 620         MEXICO: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 487

TABLE 621         MEXICO: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          487

TABLE 622         MEXICO: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  487

TABLE 623         MEXICO: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             488

TABLE 624         MEXICO: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 488

TABLE 625         MEXICO: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      489

TABLE 626         MEXICO: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      489

TABLE 627         MEXICO: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      490

TABLE 628         MEXICO: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      490

TABLE 629         MEXICO: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     491

TABLE 630         MEXICO: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      491

TABLE 631         MEXICO: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     491

TABLE 632         MEXICO: BIOMATERIALS MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      492

TABLE 633        MEXICO: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       492

8.5.4      ARGENTINA      492

8.5.4.1   Increased incidence of cardiovascular diseases to aid market growth        492

TABLE 634         ARGENTINA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 493

TABLE 635         ARGENTINA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     493

TABLE 636         ARGENTINA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     494

TABLE 637         ARGENTINA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     494

TABLE 638         ARGENTINA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     495

TABLE 639         ARGENTINA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          495

TABLE 640         ARGENTINA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      496

TABLE 641         ARGENTINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      496

TABLE 642         ARGENTINA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     497

TABLE 643         ARGENTINA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 497

TABLE 644         ARGENTINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  498

TABLE 645         ARGENTINA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             498

TABLE 646         ARGENTINA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)     499

TABLE 647         ARGENTINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              499

TABLE 648         ARGENTINA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      500

TABLE 649         ARGENTINA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      500

TABLE 650         ARGENTINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      501

TABLE 651         ARGENTINA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          501

TABLE 652         ARGENTINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       501

TABLE 653         ARGENTINA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       502

TABLE 654         ARGENTINA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      502

TABLE 655         ARGENTINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      503

8.5.5      REST OF LATIN AMERICA          503

TABLE 656         REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          503

TABLE 657         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 504

TABLE 658         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)  504

TABLE 659         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)           505

TABLE 660         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 505

TABLE 661         REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           506

TABLE 662         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              507

TABLE 663         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        507

TABLE 664         REST OF LATIN AMERICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             508

TABLE 665        REST OF LATIN AMERICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          508

TABLE 666         REST OF LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)              509

TABLE 667         REST OF LATIN AMERICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    509

TABLE 668         REST OF LATIN AMERICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             510

TABLE 669         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              510

TABLE 670         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)    511

TABLE 671         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 511

TABLE 672         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 512

TABLE 673         REST OF LATIN AMERICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    512

TABLE 674         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              513

TABLE 675         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       513

TABLE 676         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              514

TABLE 677         REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      514

8.6         MIDDLE EAST  514

TABLE 678         MIDDLE EAST: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     515

TABLE 679         MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 515

TABLE 680         MIDDLE EAST: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     516

TABLE 681         MIDDLE EAST: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     516

TABLE 682         MIDDLE EAST: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     517

TABLE 683         MIDDLE EAST: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     517

TABLE 684         MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          518

TABLE 685         MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              518

TABLE 686         MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      519

TABLE 687         MIDDLE EAST: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     519

TABLE 688         MIDDLE EAST: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 520

TABLE 689         MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  520

TABLE 690         MIDDLE EAST: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       521

TABLE 691         MIDDLE EAST: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)     521

TABLE 692         MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              522

TABLE 693         MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      522

TABLE 694         MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  523

TABLE 695         MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  523

TABLE 696         MIDDLE EAST: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          524

TABLE 697         MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       524

TABLE 698         MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       524

TABLE 699         MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      525

TABLE 700         MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      525

8.6.1      MIDDLE EAST: RECESSION IMPACT       525

8.6.2      GCC COUNTRIES           526

TABLE 701         GCC COUNTRIES: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          526

TABLE 702         GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)     526

TABLE 703         GCC COUNTRIES: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     527

TABLE 704         GCC COUNTRIES: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     527

TABLE 705         GCC COUNTRIES: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     528

TABLE 706         GCC COUNTRIES: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     528

TABLE 707         GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          529

TABLE 708         GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              529

TABLE 709         GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      530

TABLE 710         GCC COUNTRIES: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)          530

TABLE 711         GCC COUNTRIES: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)     531

TABLE 712         GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  531

TABLE 713        GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       532

TABLE 714         GCC COUNTRIES: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          532

TABLE 715         GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              533

TABLE 716         GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      533

TABLE 717         GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  534

TABLE 718         GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  534

TABLE 719         GCC COUNTRIES: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)             535

TABLE 720         GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       535

TABLE 721         GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       535

TABLE 722         GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      536

TABLE 723         GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      536

8.6.2.1   Saudi Arabia        536

8.6.2.1.1 Increasing prevalence of cardiovascular diseases to drive market 536

TABLE 724         SAUDI ARABIA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION) 537

TABLE 725         SAUDI ARABIA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     537

TABLE 726         SAUDI ARABIA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     538

TABLE 727         SAUDI ARABIA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     538

TABLE 728         SAUDI ARABIA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     539

TABLE 729         SAUDI ARABIA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          539

TABLE 730         SAUDI ARABIA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              540

TABLE 731         SAUDI ARABIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      540

TABLE 732         SAUDI ARABIA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)     541

TABLE 733         SAUDI ARABIA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION) 541

TABLE 734         SAUDI ARABIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  541

TABLE 735         SAUDI ARABIA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)       542

TABLE 736         SAUDI ARABIA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)     542

TABLE 737         SAUDI ARABIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              543

TABLE 738         SAUDI ARABIA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      543

TABLE 739         SAUDI ARABIA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  544

TABLE 740         SAUDI ARABIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  544

TABLE 741         SAUDI ARABIA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)          545

TABLE 742         SAUDI ARABIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       545

TABLE 743         SAUDI ARABIA: BIOMATERIALS MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       545

TABLE 744         SAUDI ARABIA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      546

TABLE 745         SAUDI ARABIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      546

8.6.2.2   United Arab Emirates        546

8.6.2.2.1 Growing interest in plastic surgeries and rising number of occupational injuries to drive market        546

TABLE 746         UNITED ARAB EMIRATES: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          547

TABLE 747         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 547

TABLE 748         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)  548

TABLE 749         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)           548

TABLE 750         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 549

TABLE 751         UNITED ARAB EMIRATES: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           550

TABLE 752         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              551

TABLE 753         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        551

TABLE 754         UNITED ARAB EMIRATES: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             552

TABLE 755        UNITED ARAB EMIRATES: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          552

TABLE 756         UNITED ARAB EMIRATES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)              553

TABLE 757         UNITED ARAB EMIRATES: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    553

TABLE 758         UNITED ARAB EMIRATES: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             554

TABLE 759         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              554

TABLE 760         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)    555

TABLE 761         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 555

TABLE 762         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 556

TABLE 763         UNITED ARAB EMIRATES: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    556

TABLE 764         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              557

TABLE 765         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       557

TABLE 766         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              558

TABLE 767         UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      558

8.6.2.3   Rest of GCC countries       558

TABLE 768         REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          559

TABLE 769         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 559

TABLE 770         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)  560

TABLE 771         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)           560

TABLE 772         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 561

TABLE 773         REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           562

TABLE 774         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              563

TABLE 775         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        563

TABLE 776         REST OF GCC COUNTRIES: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             564

TABLE 777         REST OF GCC COUNTRIES: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)             564

TABLE 778         REST OF GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)              565

TABLE 779         REST OF GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    565

TABLE 780         REST OF GCC COUNTRIES: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             566

TABLE 781         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              566

TABLE 782         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)    567

TABLE 783         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 567

TABLE 784         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 568

TABLE 785         REST OF GCC COUNTRIES: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)    568

TABLE 786         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              569

TABLE 787         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       569

TABLE 788         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              570

TABLE 789         REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      570

8.6.3      REST OF MIDDLE EAST 570

TABLE 790         REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          571

TABLE 791         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 571

TABLE 792         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)  572

TABLE 793         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)           572

TABLE 794         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION) 573

TABLE 795         REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           574

TABLE 796         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              575

TABLE 797         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)        575

TABLE 798         REST OF MIDDLE EAST: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)             576

TABLE 799         REST OF MIDDLE EAST: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          576

TABLE 800         REST OF MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)  577

TABLE 801         REST OF MIDDLE EAST: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    577

TABLE 802         REST OF MIDDLE EAST: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)             578

TABLE 803         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              578

TABLE 804         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      579

TABLE 805         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  579

TABLE 806         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  580

TABLE 807         REST OF MIDDLE EAST: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)       580

TABLE 808         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       581

TABLE 809         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       581

TABLE 810         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)              582

TABLE 811         REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      582

8.7         AFRICA 583

8.7.1      INCREASING FOCUS ON HEALTHCARE AND RISING NUMBER OF COLLABORATIONS TO SUPPORT MARKET GROWTH    583

TABLE 812         AFRICA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)          583

TABLE 813         AFRICA: BIOMATERIALS MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     584

TABLE 814         AFRICA: BIOMATERIALS MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     584

TABLE 815         AFRICA: BIOMATERIALS MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     585

TABLE 816         AFRICA: BIOMATERIALS MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)     585

TABLE 817         AFRICA: BIOMATERIALS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 586

TABLE 818         AFRICA: BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      586

TABLE 819         AFRICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      587

TABLE 820         AFRICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION) 587

TABLE 821         AFRICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)          588

TABLE 822         AFRICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)    588

TABLE 823        AFRICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)          589

TABLE 824         AFRICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION) 589

TABLE 825         AFRICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      590

TABLE 826         AFRICA: BIOMATERIALS MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      590

TABLE 827         AFRICA: BIOMATERIALS MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      591

TABLE 828         AFRICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      591

TABLE 829         AFRICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)     592

TABLE 830         AFRICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      592

TABLE 831         AFRICA: BIOMATERIALS MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       592

TABLE 832         AFRICA: BIOMATERIALS MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      593

TABLE 833         AFRICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       593

8.7.2      AFRICA: RECESSION IMPACT     593

9            COMPETITIVE LANDSCAPE       594

9.1         INTRODUCTION            594

9.2         RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS        595

FIGURE 30         BIOMATERIALS MARKET: STRATEGIES ADOPTED          595

9.3         REVENUE SHARE ANALYSIS       596

FIGURE 31         REVENUE ANALYSIS OF KEY PLAYERS (2020–2023)          596

9.4         MARKET SHARE ANALYSIS         597

FIGURE 32         MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)        597

TABLE 834         BIOMATERIALS MARKET: DEGREE OF COMPETITION   597

9.5         COMPANY EVALUATION MATRIX: KEY PLAYERS            599

9.5.1      STARS  599

9.5.2      EMERGING LEADERS    599

9.5.3      PERVASIVE PLAYERS     599

9.5.4      PARTICIPANTS 599

FIGURE 33         BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023     600

9.5.5      COMPANY FOOTPRINT 601

FIGURE 34         BIOMATERIALS MARKET: COMPANY FOOTPRINT          601

TABLE 835         BIOMATERIALS MARKET: TYPE FOOTPRINT     602

TABLE 836         BIOMATERIALS MARKET: REGIONAL FOOTPRINT         603

9.6         COMPANY EVALUATION MATRIX: START-UPS/SMES     604

9.6.1      PROGRESSIVE COMPANIES       604

9.6.2      RESPONSIVE COMPANIES          604

9.6.3      DYNAMIC COMPANIES 604

9.6.4      STARTING BLOCKS       604

FIGURE 35         BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023           605

9.6.5      COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS   606

TABLE 837         BIOMATERIALS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS          606

TABLE 838         BIOMATERIALS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS           607

9.7         VALUATION AND FINANCIAL METRICS OF BIOMATERIALS VENDORS              607

FIGURE 36         EV/EBITDA OF KEY VENDORS   607

FIGURE 37         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 608

9.8         BRAND/PRODUCT COMPARATIVE ANALYSIS    609

FIGURE 38         BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL              609

9.8.1      BASF SE              610

9.8.2      COVESTRO AG 610

9.8.3      CELANESE CORPORATION        610

9.8.4      CARPENTER TECHNOLOGY CORPORATION      610

9.8.5      EVONIK INDUSTRIES AG            610

9.8.6      BRAND/PRODUCT COMPARATIVE ANALYSIS, BY METALLIC BIOMATERIAL  611

FIGURE 39         BRAND/PRODUCT COMPARATIVE ANALYSIS, BY METALLIC BIOMATERIAL  611

9.8.7      CARPENTER TECHNOLOGY CORPORATION      611

9.8.8      SOLESIS             612

9.8.9      AMETEK, INC.   612

9.9         COMPETITIVE SCENARIO          612

9.9.1      PRODUCT LAUNCHES  612

TABLE 839         BIOMATERIALS MARKET: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2024       612

9.9.2      DEALS  613

TABLE 840         BIOMATERIALS MARKET: DEALS, JANUARY 2021–JANUARY 2024              613

9.9.3      EXPANSIONS    615

TABLE 841         BIOMATERIALS MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2024  615

9.9.4      OTHER DEVELOPMENTS           616

TABLE 842         BIOMATERIALS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2024       616

10          COMPANY PROFILES    617

10.1       KEY PLAYERS   617

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

10.1.1    BASF SE              617

TABLE 843         BASF SE: COMPANY OVERVIEW 617

FIGURE 40         BASF SE: COMPANY SNAPSHOT (2022)  618

TABLE 844         BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 618

TABLE 845         BASF SE: PRODUCT LAUNCHES 619

TABLE 846         BASF SE: DEALS 620

TABLE 847         BASF SE: OTHER DEVELOPMENTS         620

10.1.2    COVESTRO AG 622

TABLE 848         COVESTRO AG: COMPANY OVERVIEW  622

FIGURE 41         COVESTRO AG: COMPANY SNAPSHOT (2022)    623

TABLE 849         COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED              623

TABLE 850         COVESTRO AG: PRODUCT LAUNCHES  625

TABLE 851         COVESTRO AG: DEALS 626

TABLE 852         COVESTRO AG: OTHER DEVELOPMENTS           626

10.1.3    CELANESE CORPORATION        628

TABLE 853         CELANESE CORPORATION: COMPANY OVERVIEW         628

FIGURE 42         CELANESE CORPORATION: COMPANY SNAPSHOT (2022)              629

TABLE 854         CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   629

TABLE 855         CELANESE CORPORATION: DEALS        632

TABLE 856         CELANESE CORPORATION: EXPANSIONS           634

TABLE 857         CELANESE CORPORATION: OTHER DEVELOPMENTS    635

10.1.4    CARPENTER TECHNOLOGY CORPORATION      636

TABLE 858         CARPENTER TECHNOLOGY CORPORATION: COMPANY OVERVIEW        636

FIGURE 43         CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT (2022)          637

TABLE 859         CARPENTER TECHNOLOGY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   637

10.1.5    EVONIK INDUSTRIES AG            640

TABLE 860         EVONIK INDUSTRIES AG: COMPANY OVERVIEW             640

FIGURE 44         EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2022) 641

TABLE 861         EVONIK INDUSTRIES AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED          641

TABLE 862         EVONIK INDUSTRIES AG: PRODUCT LAUNCHES            644

TABLE 863         EVONIK INDUSTRIES AG: DEALS            645

10.1.6    DSM      646

TABLE 864         DSM: COMPANY OVERVIEW      646

FIGURE 45         DSM: COMPANY SNAPSHOT (2022)        647

TABLE 865         DSM: PRODUCTS/SERVICES/SOLUTIONS OFFERED       648

TABLE 866         DSM: DEALS     650

TABLE 867         DSM: OTHER DEVELOPMENTS 650

10.1.7    CORBION NV    651

TABLE 868         CORBION NV: COMPANY OVERVIEW     651

FIGURE 46         CORBION NV: COMPANY SNAPSHOT (2022)       652

TABLE 869         CORBION NV: PRODUCTS/SERVICES/SOLUTIONS OFFERED              652

TABLE 870         CORBION NV: DEALS    654

TABLE 871         CORBION NV: EXPANSIONS       654

10.1.8    VICTREX PLC    655

TABLE 872         VICTREX PLC: COMPANY OVERVIEW    655

FIGURE 47         VICTREX PLC: COMPANY SNAPSHOT (2022)      656

TABLE 873         VICTREX PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED              656

TABLE 874         VICTREX PLC: PRODUCT LAUNCHES    657

TABLE 875         VICTREX PLC: DEALS    657

TABLE 876         VICTREX PLC: EXPANSIONS       658

10.1.9    CERAMTEC GMBH         659

TABLE 877         CERAMTEC GMBH: COMPANY OVERVIEW         659

FIGURE 48         CERAMTEC GMBH: COMPANY SNAPSHOT (2021)            660

TABLE 878         CERAMTEC GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED          660

10.1.10  MITSUBISHI CHEMICAL CORPORATION             661

TABLE 879         MITSUBISHI CHEMICAL CORPORATION: COMPANY OVERVIEW        661

FIGURE 49         MITSUBISHI CHEMICAL CORPORATION: COMPANY SNAPSHOT (2022)          661

TABLE 880         MITSUBISHI CHEMICAL CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED   662

10.1.11  COORSTEK INC.             663

TABLE 881         COORSTEK INC.: COMPANY OVERVIEW 663

TABLE 882         COORSTEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED              663

TABLE 883         COORSTEK INC.: EXPANSIONS  664

10.1.12  BERKELEY ADVANCED BIOMATERIALS 665

TABLE 884         BERKELEY ADVANCED BIOMATERIALS: COMPANY OVERVIEW              665

TABLE 885         BERKELEY ADVANCED BIOMATERIALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED   665

10.1.13  CAM BIOCERAMICS B.V.             667

TABLE 886         CAM BIOCERAMICS B.V.: COMPANY OVERVIEW 667

TABLE 887         CAM BIOCERAMICS B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED          667

TABLE 888         CAM BIOCERAMICS B.V.: DEALS             668

10.1.14  ZEUS COMPANY INC.    669

TABLE 889         ZEUS COMPANY INC.: COMPANY OVERVIEW     669

TABLE 890         ZEUS COMPANY INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED          669

TABLE 891         ZEUS COMPANY INC.: PRODUCT LAUNCHES     671

TABLE 892         ZEUS COMPANY INC.: DEALS    672

TABLE 893         ZEUS COMPANY INC.: EXPANSIONS       672

10.1.15  AMETEK INC.    673

TABLE 894         AMETEK.INC.: COMPANY OVERVIEW    673

FIGURE 50         AMETEK.INC.: COMPANY SNAPSHOT (2022)      674

TABLE 895         AMETEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED              674

TABLE 896         AMETEK INC.: DEALS    675

TABLE 897         AMETEK.INC.: EXPANSIONS      675

10.1.16  GELITA AG        677

TABLE 898         GELITA AG: COMPANY OVERVIEW        677

TABLE 899         GELITA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED              677

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

10.2       OTHER PLAYERS           679

10.2.1    COLLAGEN SOLUTIONS (US) LLC)        679

TABLE 900         COLLAGEN SOLUTIONS (US) LLC: BUSINESS OVERVIEW              679

10.2.2    BIOCOMPOSITES           680

TABLE 901         BIOCOMPOSITES: COMPANY OVERVIEW           680

10.2.3    NOBLE BIOMATERIALS, INC.     681

TABLE 902         NOBLE BIOMATERIALS, INC.: COMPANY OVERVIEW      681

10.2.4    REGENITY         681

TABLE 903         REGENITY: COMPANY OVERVIEW          681

10.2.5    KURARAY CO., LTD.      683

TABLE 904         KURARAY CO., LTD.: COMPANY OVERVIEW       683

10.2.6    SOLESIS             684

TABLE 905         SOLESIS: COMPANY OVERVIEW 684

10.2.7    INSTITUT STRAUMANN AG       686

TABLE 906         INSTITUT STRAUMANN AG: COMPANY OVERVIEW        686

10.2.8    FOSTER CORPORATION             687

TABLE 907         FOSTER CORPORATION: COMPANY OVERVIEW             687

10.2.9    CDI PRODUCTS              688

TABLE 908         CDI PRODUCTS: COMPANY OVERVIEW 688

11          APPENDIX         689

11.1       DISCUSSION GUIDE      689

11.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             695

11.3       CUSTOMIZATION OPTIONS      697

11.4       RELATED REPORTS       697

11.5       AUTHOR DETAILS         698